486 results on '"Loutfy, Mona R."'
Search Results
2. HIV-related stigma, racial discrimination, and gender discrimination: Pathways to physical and mental health-related quality of life among a national cohort of women living with HIV
3. Lignes directrices canadiennes en matière de planification de la grossesse en présence du VIH
4. Expert consensus statement on the science of HIV in the context of criminal law
5. Piloting an online telecoaching community-based exercise intervention with adults living with HIV: protocol for a mixed-methods implementation science study
6. Adverse Neonatal Outcomes Among Women Living With HIV: A Population-Based Study
7. Issues in Applying a Harm Reduction Approach to Breastfeeding in the Context of Maternal HIV
8. HIV Protease Inhibitor Use During Pregnancy Is Associated With Decreased Progesterone Levels, Suggesting a Potential Mechanism Contributing to Fetal Growth Restriction
9. Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada
10. Retrospective Reports of Developmental Stressors, Syndemics, and Their Association with Sexual Risk Outcomes Among Gay Men
11. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
12. Drug-resistant Malaria
13. Infectious Complications of Bio-Alcamid Filler Used for HIV-Related Facial Lipoatrophy
14. The Recombinant Hepatitis B Surface Antigen Vaccine in Persons With HIV: Is Seroconversion Sufficient for Long-term Protection?
15. Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis
16. Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials
17. HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims: A Prospective Analysis
18. CD4⁺ Cell Count Increase Predicts Clinical Benefits in Patients with Advanced HIV Disease and Persistent Viremia after 1 Year of Combination Antiretroviral Therapy
19. Correlates of a lifetime history of sexually transmitted infections among women who have sex with women in Toronto, Canada: results from a cross-sectional internet-based survey
20. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells
21. Effects of Viral Hemorrhagic Fever Inactivation Methods on the Performance of Rapid Diagnostic Tests for Plasmodium falciparum
22. Examining the Traits-Desires-Intentions-Behavior (TDIB) Model for Fertility Planning in Women Living with HIV in Ontario, Canada
23. HIV Protease Inhibitors in Pregnancy: Pharmacology and Clinical Use
24. Correlates of Anxiety in Women Living with HIV of Reproductive Age
25. Once Daily Dosing Improves Adherence to Antiretroviral Therapy
26. Correlates of HIV stigma in HIV-positive women
27. Long-term efficacy and safety of raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 phase III trials
28. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history
29. Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort
30. Raltegravir with optimized background therapy for resistant HIV-1 infection
31. Subgroup and resistance analyses of Raltegravir for resistant HIV-1 infection
32. Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma
33. A prospective randomized controlled trial of structured treatment interruption in HIV-infected patients failing highly active antiretroviral therapy: (Canadian HIV trials network study 164)
34. Treatment of HIV Infection in Pregnant Women: Antiretroviral Management Options
35. Severe acute respiratory syndrome
36. Hospital preparedness and SARS
37. HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy
38. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
39. Physician Attitudes Regarding Pregnancy, Fertility Care, and Assisted Reproductive Technologies for HIV-Infected Individuals and Couples
40. Recent advances in the prophylaxis and treatment of malaria
41. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial
42. Four-Year Follow-Up of Polyalkylimide Gel Use for the Treatment of HIV-Associated Lipoatrophy
43. Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada
44. Factors affecting banking quality of umbilical cord blood for transplantation
45. Effect of Gender and Calendar Year on Time to and Duration of Virologic Suppression Among Antiretroviral-Naïve HIV-Infected Individuals Initiating Combination Antiretroviral Therapy
46. Trimethoprim-Sulfamethoxazole–Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System: A Population-Based Study
47. An Economic Evaluation of Treatments for HIV-Associated Facial Lipoatrophy: A Cost-Utility Analysis§
48. Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen
49. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients
50. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.